Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2021

01-08-2021 | Opioids | Research Article

Understanding management of poorly controlled pain in community-dwelling analgesic users: a qualitative study

Authors: Andrea J. Wilson, M. Joy Spark

Published in: International Journal of Clinical Pharmacy | Issue 4/2021

Login to get access

Abstract

Background Chronic pain is a prevalent and debilitating condition for many people. Globally it is the greatest contributor to years lived with disability. Management often includes pharmacotherapy and pharmacists are therefore well placed to contribute to chronic pain management. Objective To explore chronic pain management in community-dwelling analgesic users with poorly controlled pain and investigate potential barriers to adequate pain management. Setting Regional Victoria, Australia. Method A descriptive qualitative approach was used. People who had been prescribed an analgesic for at least 6 months and reported an average pain score over the last week of 4 or more out of 10 were interviewed about their pain management. Interviews followed a semi-structured interview guide. Thematic analysis of the data was undertaken followed by participant validation of the key themes. Main outcome measure Experience of chronic pain management. Results Three female and eight male people, aged between 34 and 77 years were interviewed. The study demonstrated that there was a diverse range of issues relating to chronic pain management that fitted into seven major themes: impact of pain on life, invisibility of pain, issues associated with healthcare professionals, general medication issues, attitude towards taking analgesics, medication adherence, and attitude towards other treatment options. Chronic pain had dramatically altered the lives of all participants and their families as they came to accept and learn to live with the pain they experienced. The main barrier to adequate pain management was the invisibility of pain, which resulted in health professionals undertreating the pain reported by participants. Participants desire to take as few analgesics as possible, the reluctance of GPs to prescribe opioids and healthcare professionals focus on misuse also contributed to poor pain management. Conclusion Participants were able to accept high levels of pain while minimizing analgesic use. The two main barriers to adequate pain management were the invisibility of pain, which resulted in health professionals not treating the pain reported by the participant and the perception of participants that analgesics should not need to be taken regularly in adequate doses for the rest of their lives.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pa Mantyselka, Ea Kumpusalo, Rb Ahonen, Ab Kumpusalo, Ja Kauhanen, Hc Viinamaki, et al. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001;89:175–80.CrossRef Pa Mantyselka, Ea Kumpusalo, Rb Ahonen, Ab Kumpusalo, Ja Kauhanen, Hc Viinamaki, et al. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001;89:175–80.CrossRef
2.
go back to reference Harstall C, Ospina M. How prevalent is chronic pain? Pain Clin. 2003;11:1–2. Harstall C, Ospina M. How prevalent is chronic pain? Pain Clin. 2003;11:1–2.
3.
go back to reference Rossi S, editor. Drugs for pain relief. Adelaide: Australian Medicines Handbook Pty Ltd.; 2019. p. 40–63. ISBN 978-0-9943262-9-4. Rossi S, editor. Drugs for pain relief. Adelaide: Australian Medicines Handbook Pty Ltd.; 2019. p. 40–63. ISBN 978-0-9943262-9-4.
5.
go back to reference Treede R-D, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160:19–27.CrossRef Treede R-D, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160:19–27.CrossRef
6.
go back to reference Honkasalo M-L. Chronic pain as a posture towards the world. Scand J Psychol. 2000;41:197–208.CrossRef Honkasalo M-L. Chronic pain as a posture towards the world. Scand J Psychol. 2000;41:197–208.CrossRef
7.
go back to reference Therapeutic Guidelines. Chronic pain: overview. eTG complete (www.tg.org.au). Melbourne: Therapeutic Guidelines Limited; 2019. Therapeutic Guidelines. Chronic pain: overview. eTG complete (www.​tg.​org.​au). Melbourne: Therapeutic Guidelines Limited; 2019.
8.
go back to reference Rice ASC, Smith BH, Blyth FM. Pain and the global burden of disease. Pain. 2016;157:791–6.CrossRef Rice ASC, Smith BH, Blyth FM. Pain and the global burden of disease. Pain. 2016;157:791–6.CrossRef
9.
go back to reference Kress H-G, Aldington D, Alon E, Coaccioli S, Collett B, Coluzzi F, et al. A holistic approach to chronic pain management that involves all stakeholders: change is needed. Curr Med Res Opin. 2015;31:1743–54.CrossRef Kress H-G, Aldington D, Alon E, Coaccioli S, Collett B, Coluzzi F, et al. A holistic approach to chronic pain management that involves all stakeholders: change is needed. Curr Med Res Opin. 2015;31:1743–54.CrossRef
11.
go back to reference Therapeutic Guidelines. Chronic pain: pharmacological management. eTG complete (www.tg.org.au). Melbourne: Therapeutic Guidelines Limited; 2019. Therapeutic Guidelines. Chronic pain: pharmacological management. eTG complete (www.​tg.​org.​au). Melbourne: Therapeutic Guidelines Limited; 2019.
12.
go back to reference Brown KE, Swift I, Spark MJ. Pain severity cut-points and analgesic use by community-dwelling people for chronic pain. J Pharm Pract Res. 2012;42:196–9.CrossRef Brown KE, Swift I, Spark MJ. Pain severity cut-points and analgesic use by community-dwelling people for chronic pain. J Pharm Pract Res. 2012;42:196–9.CrossRef
13.
14.
go back to reference Vallerand A, Nowak L. Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part I—life before and after opioid therapy. Pain Manag Nurs. 2009;10:165–72.CrossRef Vallerand A, Nowak L. Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part I—life before and after opioid therapy. Pain Manag Nurs. 2009;10:165–72.CrossRef
15.
go back to reference Vallerand A, Nowak L. Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part II—barriers to chronic opioid therapy. Pain Manag Nurs. 2010;11:126–31.CrossRef Vallerand A, Nowak L. Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part II—barriers to chronic opioid therapy. Pain Manag Nurs. 2010;11:126–31.CrossRef
16.
go back to reference DuPont RL. The opioid epidemic is an historic opportunity to improve both prevention and treatment. Brain Res Bull. 2018;138:112–4.CrossRef DuPont RL. The opioid epidemic is an historic opportunity to improve both prevention and treatment. Brain Res Bull. 2018;138:112–4.CrossRef
18.
go back to reference O’Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21:3–19.CrossRef O’Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21:3–19.CrossRef
19.
go back to reference Mikelyte R, Abrahamson V, Hill E, Wilson PM. Factors influencing trends in opioid prescribing for older people: a scoping review. Prim Health Care Res Dev. 2020;21:e36.CrossRef Mikelyte R, Abrahamson V, Hill E, Wilson PM. Factors influencing trends in opioid prescribing for older people: a scoping review. Prim Health Care Res Dev. 2020;21:e36.CrossRef
20.
go back to reference Labonte R, Robertson A. Delivering the goods, showing our stuff: the case for a constructivist paradigm for health promotion research and practice. Health Educ Quart. 1996;23:431–47.CrossRef Labonte R, Robertson A. Delivering the goods, showing our stuff: the case for a constructivist paradigm for health promotion research and practice. Health Educ Quart. 1996;23:431–47.CrossRef
21.
go back to reference Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23:334–40.CrossRef Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23:334–40.CrossRef
22.
go back to reference Liamputtong P, Ezzy D. Qualitative research methods. 2nd ed. South Melbourne: Oxford University Press; 2005. ISBN 0 19 551744 X. Liamputtong P, Ezzy D. Qualitative research methods. 2nd ed. South Melbourne: Oxford University Press; 2005. ISBN 0 19 551744 X.
23.
go back to reference Coyle N, Tickoo R. Qualitative research: what this research paradigm has to offer to the understanding of pain. Pain Med. 2007;8:205–6.CrossRef Coyle N, Tickoo R. Qualitative research: what this research paradigm has to offer to the understanding of pain. Pain Med. 2007;8:205–6.CrossRef
24.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods. 2006;18:59–82.CrossRef Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods. 2006;18:59–82.CrossRef
25.
go back to reference Taylor SJ, Bogdan R. Introduction to qualitative research methods. 3rd ed. New York: Wiley; 1998. ISBN 0471168688. Taylor SJ, Bogdan R. Introduction to qualitative research methods. 3rd ed. New York: Wiley; 1998. ISBN 0471168688.
26.
go back to reference Smith F. Research methods in pharmacy practice. London: Pharmaceutical Press; 2002. ISBN 0-85369-481-8. Smith F. Research methods in pharmacy practice. London: Pharmaceutical Press; 2002. ISBN 0-85369-481-8.
27.
go back to reference O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89:1245–51.CrossRef O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89:1245–51.CrossRef
28.
go back to reference Skúladóttir H, Gunnarsdóttir TJ, Halldórsdóttir S, Sveinsdóttir H, Holden JE, Björnsdóttir A. Breaking the vicious circle: experiences of people in chronic pain on the pain rehabilitation journey. Nurs Open. 2020;7:1412–23.CrossRef Skúladóttir H, Gunnarsdóttir TJ, Halldórsdóttir S, Sveinsdóttir H, Holden JE, Björnsdóttir A. Breaking the vicious circle: experiences of people in chronic pain on the pain rehabilitation journey. Nurs Open. 2020;7:1412–23.CrossRef
29.
go back to reference Hadi MA, Alldred DP, Briggs M, Marczewski K, Closs SJ. ‘Treated as a number, not treated as a person’: a qualitative exploration of the perceived barriers to effective pain management of patients with chronic pain. BMJ Open. 2017;7:e016454.CrossRef Hadi MA, Alldred DP, Briggs M, Marczewski K, Closs SJ. ‘Treated as a number, not treated as a person’: a qualitative exploration of the perceived barriers to effective pain management of patients with chronic pain. BMJ Open. 2017;7:e016454.CrossRef
30.
go back to reference Gjesdal K, Dysvik E, Furnes B. Living with chronic pain: patients’ experiences with healthcare services in Norway. Nurs Open. 2018;5:517–26.CrossRef Gjesdal K, Dysvik E, Furnes B. Living with chronic pain: patients’ experiences with healthcare services in Norway. Nurs Open. 2018;5:517–26.CrossRef
31.
go back to reference Becker KL. Tell me your dreams and goals: structuring communication exchanges to improve patient-centered care with chronic pain patients. Appl Nurs Res. 2020;53:151248.CrossRef Becker KL. Tell me your dreams and goals: structuring communication exchanges to improve patient-centered care with chronic pain patients. Appl Nurs Res. 2020;53:151248.CrossRef
33.
go back to reference Henry SG, Bell RA, Fenton JJ, Kravitz RL. Communication about chronic pain and opioids in primary care: impact on patient and physician visit experience. Pain. 2018;159:371–9.CrossRef Henry SG, Bell RA, Fenton JJ, Kravitz RL. Communication about chronic pain and opioids in primary care: impact on patient and physician visit experience. Pain. 2018;159:371–9.CrossRef
34.
go back to reference Staton LJ, Panda M, Chen I, Genao I, Kurz J, Pasanen M, et al. When race matters: disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc. 2007;99:532–8.PubMedPubMedCentral Staton LJ, Panda M, Chen I, Genao I, Kurz J, Pasanen M, et al. When race matters: disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc. 2007;99:532–8.PubMedPubMedCentral
35.
go back to reference Tabeefar H, Chang F, Cooke M, Patel T. Community pharmacists and chronic pain: a qualitative study of experience, perception, and challenges. Can J Pain. 2020;4:29–39.CrossRef Tabeefar H, Chang F, Cooke M, Patel T. Community pharmacists and chronic pain: a qualitative study of experience, perception, and challenges. Can J Pain. 2020;4:29–39.CrossRef
36.
go back to reference Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40:23–42.CrossRef Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40:23–42.CrossRef
37.
go back to reference Hadi MA, José Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016;38:641–6.PubMed Hadi MA, José Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016;38:641–6.PubMed
Metadata
Title
Understanding management of poorly controlled pain in community-dwelling analgesic users: a qualitative study
Authors
Andrea J. Wilson
M. Joy Spark
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01198-8

Other articles of this Issue 4/2021

International Journal of Clinical Pharmacy 4/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.